This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

AminoActiv Treatment Regimen For Pain Management Promises Significantly Lower Consumer Costs Than Traditional Prescription NSAIDs

MADISON, Tenn., April 2, 2013 /PRNewswire/ -- In a one-year period, prescriptions for non-steroidal anti-inflammatory drugs (NSAIDs) cost the average consumer $2420. There are 33 million regular users of NSAIDs, and each user on average pays an additional $700 annually to treat side effects caused by their NSAIDs prescriptions. That's the takeaway from a study of current literature commissioned by Vireo Systems, Inc., the maker of AminoActiv®, a compelling new alternative to traditional NSAIDs.

The study compared AminoActiv with both prescription and generic NSAIDs and presented the following findings:

Annual Cost of Treatment Per Person:

  • AminoActiv: $600
  • Prescription NSAIDs: $2420

Side Effects Cost:

  • AminoActiv: $0
  • Prescription NSAIDs: $700

"The costs for just the side effects component of NSAID treatment exceed the total cost of AminoActiv treatment," stated Vireo Systems president Mark Faulkner. "To express it another way, if NSAID users obtained their prescriptions for free, they still would pay more to treat NSAID side effects."

AminoActiv offers comparable levels of pain and inflammation relief for a variety of chronic and acute conditions, along with promotion of more rapid healing, no known side effects, and no known toxicities or drug interactions.

Alternatives to NSAID treatment, including AminoActiv, are gaining traction for two major reasons. First, consumers are becoming more cognizant of the risks inherent in standard prescriptions like ibuprofen, naproxen (e.g. Naprosyn®), celecoxib (e.g. Celebrex®), and diclofenac. These risks include gastrointestinal issues, renal problems and cardiac complications. The risks are even greater for senior citizens. It is common for these side effects to result in hospitalization that costs between $15,000 and $20,000.

Second, there is a large group of consumers whose chronic diseases or organ sensitivities discourage or prevent them from using NSAIDs to alleviate pain.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,884.69 -100.92 -0.59%
S&P 500 1,963.44 -9.39 -0.48%
NASDAQ 4,395.0780 -23.9560 -0.54%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs